Evidence map›Paper›PMID 33905023›Full record

ArticleAMB Express2021

Periplasmic synthesis and purification of the human prolactin antagonist Δ

Miriam F Suzuki, Larissa A Almeida, Stephanie A Pomin, Felipe D Silva, Renan P Freire, João E Oliveira, Regina Affonso, Carlos R J Soares, Paolo Bartolini

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AMB Express, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Miriam F SuzukiBiotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP, Avenida Prof. Lineu Prestes 2242, São Paulo, SP, 05508-000, Brazil.ORCID http://orcid.org/0000-0002-7467-3457
Larissa A AlmeidaBiotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP, Avenida Prof. Lineu Prestes 2242, São Paulo, SP, 05508-000, Brazil.ORCID http://orcid.org/0000-0002-0354-8384
Stephanie A PominBiotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP, Avenida Prof. Lineu Prestes 2242, São Paulo, SP, 05508-000, Brazil.ORCID http://orcid.org/0000-0001-5637-2303
Felipe D SilvaBiotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP, Avenida Prof. Lineu Prestes 2242, São Paulo, SP, 05508-000, Brazil.ORCID http://orcid.org/0000-0003-2617-7739
Renan P FreireBiotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP, Avenida Prof. Lineu Prestes 2242, São Paulo, SP, 05508-000, Brazil.ORCID http://orcid.org/0000-0003-3926-5981
João E OliveiraBiotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP, Avenida Prof. Lineu Prestes 2242, São Paulo, SP, 05508-000, Brazil.ORCID http://orcid.org/0000-0002-6937-1120
Regina AffonsoBiotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP, Avenida Prof. Lineu Prestes 2242, São Paulo, SP, 05508-000, Brazil.ORCID http://orcid.org/0000-0002-9264-4262
Carlos R J SoaresBiotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP, Avenida Prof. Lineu Prestes 2242, São Paulo, SP, 05508-000, Brazil.ORCID http://orcid.org/0000-0002-7982-1789
Paolo BartoliniBiotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP, Avenida Prof. Lineu Prestes 2242, São Paulo, SP, 05508-000, Brazil. pbartoli@ipen.br.ORCID http://orcid.org/0000-0002-5258-1527
Instituto de Pesquisas Energéticas e Nucleares · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 3152/2018-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2012/24345-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2015/26058-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/50332-0Instituto de Pesquisas Energéticas e Nucleares, IPEN - CNEN/SP 4/2017
6 · The paper itself

Abstract

The human prolactin antagonist Δ

Indexed as

Antagonistic propertiesDsbA signal peptidePeriplasmic expressionProlactin antagonist

Identifiers

PMID33905023
PMCPMC8079533
OpenAlexW3136253483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.